Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 6/10

vs
industry
vs
history
Cash to Debt 0.12
XRAY's Cash to Debt is ranked lower than
52% of the 312 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.04 vs. XRAY: 0.12 )
XRAY' s 10-Year Cash to Debt Range
Min: 0.03   Max: 0.96
Current: 0.12

0.03
0.96
Equity to Asset 0.50
XRAY's Equity to Asset is ranked higher than
62% of the 304 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 0.57 vs. XRAY: 0.50 )
XRAY' s 10-Year Equity to Asset Range
Min: 0.34   Max: 0.6
Current: 0.5

0.34
0.6
Interest Coverage 9.50
XRAY's Interest Coverage is ranked higher than
55% of the 173 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 32.94 vs. XRAY: 9.50 )
XRAY' s 10-Year Interest Coverage Range
Min: 4.1   Max: 29.14
Current: 9.5

4.1
29.14
F-Score: 8
Z-Score: 3.97
M-Score: -2.86
WACC vs ROIC
9.68%
9.44%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 8/10

vs
industry
vs
history
Operating margin (%) 15.25
XRAY's Operating margin (%) is ranked higher than
88% of the 309 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 9.43 vs. XRAY: 15.25 )
XRAY' s 10-Year Operating margin (%) Range
Min: 4.25   Max: 18.42
Current: 15.25

4.25
18.42
Net-margin (%) 11.05
XRAY's Net-margin (%) is ranked higher than
84% of the 309 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 5.28 vs. XRAY: 11.05 )
XRAY' s 10-Year Net-margin (%) Range
Min: 2.65   Max: 14.94
Current: 11.05

2.65
14.94
ROE (%) 12.96
XRAY's ROE (%) is ranked higher than
85% of the 298 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 8.60 vs. XRAY: 12.96 )
XRAY' s 10-Year ROE (%) Range
Min: 3.38   Max: 21.51
Current: 12.96

3.38
21.51
ROA (%) 6.52
XRAY's ROA (%) is ranked higher than
82% of the 313 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 3.93 vs. XRAY: 6.52 )
XRAY' s 10-Year ROA (%) Range
Min: 1.74   Max: 11.68
Current: 6.52

1.74
11.68
ROC (Joel Greenblatt) (%) 37.74
XRAY's ROC (Joel Greenblatt) (%) is ranked higher than
89% of the 311 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 19.59 vs. XRAY: 37.74 )
XRAY' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: 12.14   Max: 86.56
Current: 37.74

12.14
86.56
Revenue Growth (3Y)(%) 4.70
XRAY's Revenue Growth (3Y)(%) is ranked higher than
72% of the 263 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 5.70 vs. XRAY: 4.70 )
XRAY' s 10-Year Revenue Growth (3Y)(%) Range
Min: 3.8   Max: 21.5
Current: 4.7

3.8
21.5
EBITDA Growth (3Y)(%) 14.50
XRAY's EBITDA Growth (3Y)(%) is ranked higher than
83% of the 235 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 5.00 vs. XRAY: 14.50 )
XRAY' s 10-Year EBITDA Growth (3Y)(%) Range
Min: -22.4   Max: 50.5
Current: 14.5

-22.4
50.5
EPS Growth (3Y)(%) 9.60
XRAY's EPS Growth (3Y)(%) is ranked higher than
77% of the 229 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 8.10 vs. XRAY: 9.60 )
XRAY' s 10-Year EPS Growth (3Y)(%) Range
Min: -32.7   Max: 88.3
Current: 9.6

-32.7
88.3
» XRAY's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

Q1 2014

XRAY Guru Trades in Q1 2014

Jim Simons 729,258 sh (New)
Chuck Royce 252,318 sh (+0.80%)
Vanguard Health Care Fund 2,826,100 sh (unchged)
Robert Olstein 113,000 sh (unchged)
Jeremy Grantham Sold Out
Steven Cohen Sold Out
Mario Gabelli 189,740 sh (-5.62%)
Paul Tudor Jones 12,959 sh (-27.49%)
» More
Q2 2014

XRAY Guru Trades in Q2 2014

Joel Greenblatt 72,218 sh (New)
Mario Gabelli 189,740 sh (unchged)
Vanguard Health Care Fund 2,826,100 sh (unchged)
Chuck Royce 232,588 sh (-7.82%)
Paul Tudor Jones 9,906 sh (-23.56%)
Robert Olstein 70,000 sh (-38.05%)
Jim Simons 247,658 sh (-66.04%)
» More
Q3 2014

XRAY Guru Trades in Q3 2014

Jean-Marie Eveillard 114,805 sh (New)
Joel Greenblatt 287,229 sh (+297.72%)
Jim Simons 425,158 sh (+71.67%)
Chuck Royce 239,988 sh (+3.18%)
Paul Tudor Jones 10,056 sh (+1.51%)
Vanguard Health Care Fund 2,826,100 sh (unchged)
Robert Olstein 70,000 sh (unchged)
Mario Gabelli 187,280 sh (-1.30%)
» More
Q4 2014

XRAY Guru Trades in Q4 2014

Joel Greenblatt 939,130 sh (+226.96%)
Jean-Marie Eveillard 315,056 sh (+174.43%)
Vanguard Health Care Fund 3,258,900 sh (+15.31%)
Chuck Royce 243,128 sh (+1.31%)
Jim Simons Sold Out
Robert Olstein Sold Out
Mario Gabelli 174,840 sh (-6.64%)
Paul Tudor Jones 7,604 sh (-24.38%)
» More
» Details

Insider Trades

Latest Guru Trades with XRAY

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Ratios

vs
industry
vs
history
P/E(ttm) 23.20
XRAY's P/E(ttm) is ranked higher than
88% of the 339 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 56.80 vs. XRAY: 23.20 )
XRAY' s 10-Year P/E(ttm) Range
Min: 12.19   Max: 116
Current: 23.2

12.19
116
Forward P/E 19.12
XRAY's Forward P/E is ranked higher than
88% of the 339 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 61.73 vs. XRAY: 19.12 )
N/A
PE(NRI) 23.10
XRAY's PE(NRI) is ranked higher than
89% of the 339 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 58.30 vs. XRAY: 23.10 )
XRAY' s 10-Year PE(NRI) Range
Min: 12.2   Max: 116
Current: 23.1

12.2
116
P/B 3.10
XRAY's P/B is ranked higher than
69% of the 339 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.08 vs. XRAY: 3.10 )
XRAY' s 10-Year P/B Range
Min: 2.07   Max: 4.65
Current: 3.1

2.07
4.65
P/S 2.59
XRAY's P/S is ranked higher than
63% of the 339 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 3.32 vs. XRAY: 2.59 )
XRAY' s 10-Year P/S Range
Min: 1.58   Max: 3.59
Current: 2.59

1.58
3.59
PFCF 16.50
XRAY's PFCF is ranked higher than
96% of the 339 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 97.29 vs. XRAY: 16.50 )
XRAY' s 10-Year PFCF Range
Min: 12.39   Max: 28.2
Current: 16.5

12.39
28.2
POCF 13.26
XRAY's POCF is ranked higher than
90% of the 339 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 28.60 vs. XRAY: 13.26 )
XRAY' s 10-Year POCF Range
Min: 10.41   Max: 21.82
Current: 13.26

10.41
21.82
EV-to-EBIT 18.75
XRAY's EV-to-EBIT is ranked higher than
87% of the 339 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 36.87 vs. XRAY: 18.75 )
XRAY' s 10-Year EV-to-EBIT Range
Min: 9.8   Max: 71.7
Current: 18.75

9.8
71.7
PEG 3.30
XRAY's PEG is ranked higher than
90% of the 339 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 0.00 vs. XRAY: 3.30 )
XRAY' s 10-Year PEG Range
Min: 0.58   Max: 80.69
Current: 3.3

0.58
80.69
Shiller P/E 25.70
XRAY's Shiller P/E is ranked higher than
94% of the 339 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 0.00 vs. XRAY: 25.70 )
XRAY' s 10-Year Shiller P/E Range
Min: 15.92   Max: 37.32
Current: 25.7

15.92
37.32
Current Ratio 1.85
XRAY's Current Ratio is ranked higher than
62% of the 309 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.62 vs. XRAY: 1.85 )
XRAY' s 10-Year Current Ratio Range
Min: 1.2   Max: 3.65
Current: 1.85

1.2
3.65
Quick Ratio 1.25
XRAY's Quick Ratio is ranked higher than
62% of the 309 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.77 vs. XRAY: 1.25 )
XRAY' s 10-Year Quick Ratio Range
Min: 0.76   Max: 2.79
Current: 1.25

0.76
2.79
Days Inventory 119.44
XRAY's Days Inventory is ranked higher than
75% of the 339 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 133.28 vs. XRAY: 119.44 )
XRAY' s 10-Year Days Inventory Range
Min: 90.27   Max: 150.84
Current: 119.44

90.27
150.84
Days Sales Outstanding 53.28
XRAY's Days Sales Outstanding is ranked higher than
85% of the 339 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 69.74 vs. XRAY: 53.28 )
XRAY' s 10-Year Days Sales Outstanding Range
Min: 51.46   Max: 61.92
Current: 53.28

51.46
61.92

Dividend & Buy Back

vs
industry
vs
history
Dividend Yield 0.52
XRAY's Dividend Yield is ranked lower than
80% of the 152 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.28 vs. XRAY: 0.52 )
XRAY' s 10-Year Dividend Yield Range
Min: 0.35   Max: 0.85
Current: 0.52

0.35
0.85
Dividend Payout 0.12
XRAY's Dividend Payout is ranked higher than
97% of the 339 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 0.00 vs. XRAY: 0.12 )
XRAY' s 10-Year Dividend Payout Range
Min: 0.07   Max: 0.45
Current: 0.12

0.07
0.45
Dividend growth (3y) 8.90
XRAY's Dividend growth (3y) is ranked higher than
78% of the 129 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 9.20 vs. XRAY: 8.90 )
XRAY' s 10-Year Dividend growth (3y) Range
Min: 3.2   Max: 14.8
Current: 8.9

3.2
14.8
Yield on cost (5-Year) 0.68
XRAY's Yield on cost (5-Year) is ranked lower than
70% of the 155 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.60 vs. XRAY: 0.68 )
XRAY' s 10-Year Yield on cost (5-Year) Range
Min: 0.48   Max: 1.15
Current: 0.68

0.48
1.15
Share Buyback Rate -0.20
XRAY's Share Buyback Rate is ranked higher than
86% of the 221 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: -2.00 vs. XRAY: -0.20 )
XRAY' s 10-Year Share Buyback Rate Range
Min: 2.2   Max: -1.3
Current: -0.2

Valuation & Return

vs
industry
vs
history
Price/DCF (Projected) 1.30
XRAY's Price/DCF (Projected) is ranked higher than
91% of the 339 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 7.80 vs. XRAY: 1.30 )
XRAY' s 10-Year Price/DCF (Projected) Range
Min: 1.08   Max: 2.1
Current: 1.3

1.08
2.1
Price/Median PS Value 1.10
XRAY's Price/Median PS Value is ranked higher than
78% of the 339 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.40 vs. XRAY: 1.10 )
XRAY' s 10-Year Price/Median PS Value Range
Min: 0.62   Max: 1.44
Current: 1.1

0.62
1.44
Price/Peter Lynch Fair Value 3.20
XRAY's Price/Peter Lynch Fair Value is ranked higher than
89% of the 339 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 0.00 vs. XRAY: 3.20 )
XRAY' s 10-Year Price/Peter Lynch Fair Value Range
Min: 0.87   Max: 8.04
Current: 3.2

0.87
8.04
Earnings Yield (Greenblatt) 5.40
XRAY's Earnings Yield (Greenblatt) is ranked higher than
86% of the 304 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 3.20 vs. XRAY: 5.40 )
XRAY' s 10-Year Earnings Yield (Greenblatt) Range
Min: 1.4   Max: 10.2
Current: 5.4

1.4
10.2
Forward Rate of Return (Yacktman) 11.97
XRAY's Forward Rate of Return (Yacktman) is ranked higher than
78% of the 165 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 10.90 vs. XRAY: 11.97 )
XRAY' s 10-Year Forward Rate of Return (Yacktman) Range
Min: -5.1   Max: 33.3
Current: 11.97

-5.1
33.3

Business Description

Industry: Medical Instruments & Equipment » Medical Instruments & Supplies
Compare:WST, BAX, COV, TMO, COO » details
Traded in other countries:DY2.Germany,
DENTSPLY International, Inc. was incorporated in 1899 in Delaware. The Company is a designer, developer, manufacturer and marketer of consumable dental products for the professional dental market. The Company also manufactures and markets other consumable medical device products. The Company's main product categories are dental consumable products, dental laboratory products, dental specialty products and consumable medical device products. The Company conducted its business through four operating segments. All of the Company's segments are mainly engaged in the design, manufacture and distribution of dental and medical products in four principal product categories: dental consumable products; dental laboratory products; dental specialty products; and consumable medical device products. Dental consumable products consist of dental sundries and small equipment used in dental offices for the treatment of patients. The Company's dental sundry products in the dental consumable products category include dental anesthetics, prophylaxis paste, dental sealants, impression materials, restorative materials, tooth whiteners and topical fluoride. Dental laboratory products are used in the preparation of dental appliances by dental laboratories. The Company's products in the dental laboratory products category include dental prosthetics, including artificial teeth, precious metal dental alloys, dental ceramics and crown and bridge materials. Dental specialty products are specialized treatment products used within the dental office and laboratory settings. The Company's products in this category include endodontic (root canal) instruments and materials, implants and related products, bone grafting materials, 3D digital implantology, dental lasers and orthodontic appliances and accessories. Consumable medical device products consist mainly of urological products including catheters, certain surgical products, medical drills and other non-medical products. The Company conducts its business in the United States of America ('U.S.'), as well as in over 120 foreign countries, principally through its foreign subsidiaries. The Company has presence in the European market, particularly in Germany, Sweden, Switzerland, France, Italy and the United Kingdom as well as in Canada. The Company also has market presence in the countries of the Commonwealth of Independent States ('CIS'), Central and South America and the Pacific Rim. The Company's products are subject to regulation by, among other governmental entities, the U.S. Food and Drug Administration.
» More Articles for XRAY

Headlines

Articles On GuruFocus.com
DENTSPLY´s Growth Opportunities Dec 16 2014 
Weekly Insider Sells Highlight: ORCL, ALXN, WAT, XRAY Dec 08 2014 
Why I Like These Two Health Care Stocks Aug 29 2014 
Global for Resilience – Columbia Management Selling Update Aug 29 2013 
4stars, lots of buys Dec 21 2011 
New Guru Added: Ray Dalio of Bridgewater Associates Dec 02 2011 
DENTSPLY International Inc. Reports Operating Results (10-K) Feb 18 2011 
Align Technologies Takes One in the Teeth Apr 06 2010 
Tom Gayner Top Buys: ITC Holdings Corp., Patterson Companies Inc., Schlumberger Ltd., Walgreen Compa Nov 09 2009 
Richard Aster Jr Buys Zebra Technologies Corp., Bunge Ltd., Liz Claiborne Inc., Sells Time Warner In Nov 03 2006 

More From Other Websites
DENTSPLY International Schedules First Quarter 2015 Earnings Release and Conference Call Apr 21 2015
These 10 Pharma and Health Care Stocks Were the Worst S&P 500 Performers Last Quarter Apr 02 2015
DENTSPLY: Product Portfolio Strong, Currency Woes Remain - Analyst Blog Mar 19 2015
Dentists see green on St Paddy's Mar 17 2015
DENTSPLY INTERNATIONAL INC /DE/ Financials Feb 27 2015
DENTSPLY International Inc. Increases Quarterly Cash Dividend Feb 24 2015
10-K for DENTSPLY International, Inc. Feb 22 2015
DENTSPLY INTERNATIONAL INC /DE/ Files SEC form 10-K, Annual Report Feb 20 2015
DENTSPLY Internatl (XRAY) Earnings Report: Q4 2014 Conference Call Transcript Feb 18 2015
DENTSPLY Lags Q4 Earnings, Revenues; FY15 Outlook Grim - Analyst Blog Feb 18 2015
DENTSPLY Misses Q4 Earnings, Revenues Down Y/Y - Tale of the Tape Feb 18 2015
DENTSPLY International Inc Earnings Call scheduled for 8:30 am ET today Feb 18 2015
DENTSPLY International Reports Fourth Quarter and Fiscal 2014 Results Feb 18 2015
DENTSPLY INTERNATIONAL INC /DE/ Files SEC form 8-K, Results of Operations and Financial Condition,... Feb 18 2015
Dentsply misses 4Q revenue forecasts Feb 18 2015
Dentsply misses 4Q revenue forecasts Feb 18 2015
Q4 2014 DENTSPLY International Inc Earnings Release - Before Market Open Feb 18 2015
DENTSPLY International Reports Fourth Quarter and Fiscal 2014 Results Feb 18 2015
Will DENTSPLY International (XRAY) Miss Earnings in Q4? - Analyst Blog Feb 16 2015
Another absolutely wild day on Wall Street Jan 30 2015

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK